(Q37420953)

English

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

scientific article published on April 2004

In more languages

Statements

scholarly article

1 reference

20 August 2017

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program (English)

1 reference

20 August 2017

3

object named as

Lee H Harrison

1 reference

20 August 2017

1

object named as

Rana A Hajjeh

1 reference

20 August 2017

Beth A Arthington-Skaggs

5

object named as

Beth A Arthington-Skaggs

1 reference

20 August 2017

David W. Warnock

16

object named as

David W Warnock

1 reference

20 August 2017

author name string

Andre N Sofair

2

1 reference

20 August 2017

G Marshall Lyon

4

1 reference

20 August 2017

Sara A Mirza

6

1 reference

20 August 2017

Maureen Phelan

7

1 reference

20 August 2017

Juliette Morgan

8

1 reference

20 August 2017

Wendy Lee-Yang

9

1 reference

20 August 2017

Meral A Ciblak

10

1 reference

20 August 2017

Lynette E Benjamin

11

1 reference

20 August 2017

Laurie Thomson Sanza

12

1 reference

20 August 2017

Sharon Huie

13

1 reference

20 August 2017

Siew Fah Yeo

14

1 reference

20 August 2017

Mary E Brandt

15

1 reference

20 August 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

20 August 2017

Journal of Clinical Microbiology

1 reference

20 August 2017

42

1 reference

20 August 2017

1519-1527

1 reference

20 August 2017

4

1 reference

20 August 2017

Resolution of discrepant results for Candida species identification by using DNA probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Has antifungal susceptibility testing come of age?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Fluconazole prophylaxis against fungal colonization and infection in preterm infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Evaluation of a reformulated CHROMagar Candida

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Yeast identification in the clinical microbiology laboratory: phenotypical methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Candida dubliniensis fungemia: the first four cases in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Rapid identification of Candida species with species-specific DNA probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

23 August 2017

Importance of Candida species other than C. albicans as pathogens in oncology patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

14 September 2017

Monitoring hospital-acquired infections to promote patient safety--United States, 1990-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

28 September 2017

Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

28 September 2017

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

26 June 2018

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

26 June 2018

Attributable mortality of nosocomial candidemia, revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Risk of low birth weight infants among black and white parents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 September 2018

Risk factors for death in patients with candidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387610

2 October 2018

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of candidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contribution of fluconazole to the changing epidemiology of invasive candidal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive candidiasis: turning risk into a practical prevention policy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candidemia in French hospitals: incidence rates and characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15070998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.42.4.1519-1527.2004

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37420953&oldid=1705386900"